Bone Marrow MMP-9 Expression Mediates Therapeutic Effect of Selective CXCR4 Antagonist AMD3100 on Myocardial Infarction

被引：0

作者：

Jujo, Kentaro ^{[1
]}

Ii, Masaaki ^{[2
]}

Sekiguchi, Haruki ^{[1
]}

Hamada, Hiromichi ^{[1
]}

Thorne, Tina ^{[1
]}

Klyachko, Ekaterina ^{[1
]}

Clarke, Trevor ^{[1
]}

Ito, Aiko ^{[1
]}

Misener, Sol ^{[1
]}

Renault, Marie-Ange ^{[1
]}

Losordo, Douglas W. ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch, Chicago, IL 60611 USA

[2] Inst BioMed Rsch & Innovat, Kobe, Hyogo, Japan

来源：

CIRCULATION | 2008年 / 118卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S536 / S537

页数：2

共 50 条

[41] Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
Broxmeyer, HE
Orschell, CM
Clapp, DW
Hangoc, G
Cooper, S
Plett, PA
Liles, WC
Li, XX
Graham-Evans, B
Campbell, TB
Calandra, G
Bridger, G
Dale, DC
Srour, EF
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08): : 1307 - 1318
[42] Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers
De Clercq, Erik
PHARMACOLOGY & THERAPEUTICS, 2010, 128 (03) : 509 - 518
[43] Chronic AMD3100 antagonism of SDF-1α-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction
Dai, Shujing
Yuan, Fangping
Mu, Jingyao
Li, Chengxin
Chen, Ning
Guo, Shangzhi
Kingery, Justin
Prabhu, Sumanth D.
Bolli, Roberto
Rokosh, Gregg
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2010, 49 (04) : 587 - 597
[44] CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
Azab, Abdel Kareem
Runnels, Judith M.
Pitsillides, Costas
Moreau, Anne-Sophie
Azab, Feda
Leleu, Xavier
Jia, Xiaoying
Wright, Renee
Ospina, Beatriz
Carlson, Alicia L.
Alt, Clemens
Burwick, Nicholas
Roccaro, Aldo M.
Ngo, Hai T.
Farag, Mena
Melhem, Molly R.
Sacco, Antonio
Munshi, Nikhil C.
Hideshima, Teru
Rollins, Barrett J.
Anderson, Kenneth C.
Kung, Andrew L.
Lin, Charles P.
Ghobrial, Irene M.
BLOOD, 2009, 113 (18) : 4341 - 4351
[45] CXCR4-selective antagonist AMD3100 accelerates impaired wound healing in diabetic mice
Nishimura, Y.
Ii, M.
Asai, J.
Takenaka, H.
Katoh, N.
Hamada, H.
Qin, G.
Losordo, D. W.
Kishimoto, S.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S4 - S4
[46] CXCR4 and MMP-9 in prostate cancer bone metastasis
Chinni, SR
Dong, Z
Sivalogan, S
Trindade, JC
Bhagat, S
Bonfil, R
Cher, ML
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1577 - 1578
[47] CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation
Zhou, Jun
Le, Kehao
Xu, Ming
Ming, Jie
Yang, Wen
Zhang, Qiulei
Lu, Linlin
Xi, Zihan
Ruan, Shengnan
Huang, Tao
MOLECULAR THERAPY ONCOLYTICS, 2020, 18 : 161 - 170
[48] The SDF-1/CXCR4 pathway is involved in the homing of chronic lymphocytic leukemia B cells and in their survival after migration into bone marrow stromal layers: inhibition by the CXCR4 antagonist (AMD3100)
Lagneaux, L
Delforge, A
Dejeneffe, M
Schols, D
Bron, D
EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 54 - 54
[49] Evaluation of CXCR4 expression in experimental brain tumor xenografts with [64Cu]AMD3100
Nimmagadda, Sridhar
Pullambhatla, Mrudula
Green, Gilbert
Bhujwalla, Zaver
Pomper, Martin
JOURNAL OF NUCLEAR MEDICINE, 2010, 51
[50] Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus composition
Fransen, Signe
Bridger, Gary
Whitcomb, Jeannette M.
Toma, Jonathan
Stawiski, Eric
Parkin, Neil
Petropoulos, Christos J.
Huang, Wei
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (07) : 2608 - 2615

← 1 2 3 4 5 →